We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Jung, Hyunsul![]() |
|
dc.contributor.author | Pitout, Johann D.D.![]() |
|
dc.contributor.author | Mitton, Barend C.![]() |
|
dc.contributor.author | Strydom, Kathy-Anne![]() |
|
dc.contributor.author | Kingsburgh, Chanel![]() |
|
dc.contributor.author | Coetzee, Jennifer![]() |
|
dc.contributor.author | Ehlers, Marthie Magdaleen![]() |
|
dc.contributor.author | Kock, Marleen M.![]() |
|
dc.date.accessioned | 2022-06-30T08:39:16Z | |
dc.date.available | 2022-06-30T08:39:16Z | |
dc.date.issued | 2021-06 | |
dc.description | TABLE S1: The Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test results in comparison with the reference broth microdilution (BMD). | en_US |
dc.description.abstract | INTRODUCTION : Colistin is one of the last-resort antibiotics for treating multidrug-resistant (MDR) or extensively drug-resistant (XDR) lactose non-fermenting Gram-negative bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii. GAP STATEMENT : As the rate of colistin resistance is steadily rising, there is a need for rapid and accurate antimicrobial susceptibility testing methods for colistin. The Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test has recently been developed for rapid detection of colistin resistance in P. aeruginosa and A. baumannii. AIM : The present study aimed to evaluate the performance of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test in comparison with the reference broth microdilution (BMD) method. METHODOLOGY : The Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test was performed using a total of 135 P. aeruginosa (17 colistin-resistant and 118 colistin-susceptible) and 66 A. baumannii isolates (32 colistin-resistant and 34 colistin-susceptible), in comparison with the reference BMD method. RESULTS : The categorical agreement of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test with the reference BMD method was 97.5 % with a major error rate of 0 % (0/152) and a very major error (VME) rate of 10.2 %. The VME rate was higher (23.5 %) when calculated separately for P. aeruginosa isolates. The overall sensitivity and specificity were 89.8 and 100 %, respectively. CONCLUSION : The Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test performed better for A. baumannii than for P. aeruginosa. | en_US |
dc.description.department | Medical Microbiology | en_US |
dc.description.librarian | hj2022 | en_US |
dc.description.sponsorship | The National Health Laboratory Service Research trust. | en_US |
dc.description.uri | https://www.microbiologyresearch.org/content/journal/jmm | en_US |
dc.identifier.citation | Jung, H., Pitout, J.D.D., Mitton, B.C. et al., Evaluation of the rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test for rapid colistin resistance detection in lactose non-fermenting Gram-negative bacteria. Journal of Medical Microbiology 2021;70:001373, DOI 10.1099/jmm.0.001373. | en_US |
dc.identifier.issn | 0022-2615 (print) | |
dc.identifier.issn | 1473-5644 (online) | |
dc.identifier.other | 10.1099/jmm.0.001373 | |
dc.identifier.uri | https://repository.up.ac.za/handle/2263/86006 | |
dc.language.iso | en | en_US |
dc.publisher | Microbiology Society | en_US |
dc.rights | © 2021 The Authors. This is a open access article. | en_US |
dc.subject | Colistin | en_US |
dc.subject | Acinetobacter baumannii | en_US |
dc.subject | Pseudomonas aeruginosa | en_US |
dc.subject | Rapid resistance detection test | en_US |
dc.subject | Multidrug-resistant (MDR) | en_US |
dc.subject | Extensively drug-resistant (XDR) | en_US |
dc.title | Evaluation of the rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test for rapid colistin resistance detection in lactose non-fermenting Gram-negative bacteria | en_US |
dc.type | Article | en_US |